Workflow
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DNUT
GlobeNewswire News Room· 2025-06-13 15:52
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the “Class Period”), of the important July 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased Krispy Kreme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...
CoreWeave Guides $4.9-$5.1B in 2025 Revenues: What's Fueling This?
ZACKS· 2025-06-13 15:51
Key Takeaways CoreWeave expects 2025 revenues between $4.9B and $5.1B amid soaring AI infrastructure demand. CRWV's OpenAI deal and a $4B expansion with a big AI enterprise client drive revenue visibility. CRWV now operates 33 data centers and has added 1,400 customers via the Weights and Biases acquisition.CoreWeave, Inc. (CRWV) has guided 2025 revenues to be in the range of $4.9-$5.1 billion, fueled by surging AI-infrastructure demand. CRWV is an AI-focused hyperscaler company and its cloud platform has ...
Parker-Hannifin Exhibits Strong Prospects Despite Persisting Headwinds
ZACKS· 2025-06-13 15:51
Key Takeaways PH's Aerospace Systems organic sales rose 12% in Q3, driven by OEM and aftermarket demand. Fiscal 2025 Aerospace sales are projected to grow 12% on air transport and defense market strength. PH targets 4-6% revenue growth by FY29, aided by acquisitions, CapEx reinvestment and its Win strategy.Parker-Hannifin Corporation (PH) is benefiting from strong momentum in the Aerospace Systems segment, driven by strength in the commercial and military end markets across both OEM and aftermarket channe ...
Aramis Group - 2025 half-year financial report release
Globenewswire· 2025-06-13 15:51
PRESS RELEASE Arcueil, June 13, 2025 2025 half-year financial report release Aramis Group today announces that the company has filed its 2025 half-year financial report, ended March 31, 2025, with the French Financial Markets Authority (Autorité des marchés financiers). Aramis Group 2025 half-year financial report is available on the Company’s website www.aramis.group under “Investors / Regulated information”. *** About Aramis Group – www.aramis.group Aramis Group is the European leader for B2C online used ...
This Dividend King's Hike Is Bigger Than You Think
The Motley Fool· 2025-06-13 15:50
Target boosts its payout to run its streak to 54 years of increases, but that's not the real story here.Target (TGT -2.27%) made it official on Thursday. The mass-market retailer lived to keep its Dividend King crown another year. Target boosted its quarterly dividend rate, something that the chain operator has now done for 54 consecutive years.It wasn't much of an increase. The new quarterly distribution rate of $1.14 a share is just a pair of pennies -- or 1.8% -- higher than the old dividend. Target stoc ...
Kvika banki hf: Kvika’s Board responds to merger proposals
Globenewswire· 2025-06-13 15:48
Group 1 - Kvika banki hf. received merger proposals from Arion banki hf. and Íslandsbanki hf. on May 27 and 28 [1] - The Board of Kvika concluded that the proposals do not reflect the intrinsic value of the bank and decided against entering merger discussions [2] - The Board believes there are significant opportunities for value creation through a potential business combination, and is open to reevaluating its decision if improved proposals are presented [3]
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
Globenewswire· 2025-06-13 15:47
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to the FDA.The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on PolTREG’s Pediatric Investigation Plan (PIP) for PTG-007 in pre-symptomatic type 1 diabetes (Stage 1). Gdańsk, Poland – 13 JUNE 2025 – PolTREG S.A. (Warsaw Stock Exch ...
Higher Gulf Oil Output Puts These Energy Names in Play
MarketBeat· 2025-06-13 15:46
There comes a time in the economic cycle when investors need to dig deeper into fundamentals and stay true to the market’s nature of reflecting tomorrow’s expectations in today’s prices; some developments are acting as a tailwind behind the energy sector of the United States, tailwinds that may lead more capital to rotate into a few specific stocks with all the right fundamental makeup moving forward. Knowing that the sector is one of the most sensitive to the overall economic cycle, it makes sense to see t ...
Allegion to Boost Product Portfolio With the Acquisition of ELATEC
ZACKS· 2025-06-13 15:46
Key Takeaways ALLE will acquire ELATEC for $379.1 million to strengthen its global access technology capabilities. ELATEC adds RFID expertise and supports nearly 100 credential types in global markets. The deal supports ALLE's growth via acquisitions, enhancing non-residential electronics offerings.Allegion plc (ALLE) recently inked a definitive deal to acquire ELATEC, including Elatec GmbH and other group entities (ELATEC), from Summit Partners through one of its subsidiaries. The deal is valued at €330 ...
Lilly Moves Past 50-Day Average: Should You Buy the Stock Now?
ZACKS· 2025-06-13 15:46
Key Takeaways LLY stock crossed its 50-day SMA, signaling potential bullish momentum after recent underperformance. Mounjaro and Zepbound drove about 48% of Q1 revenues, aided by global launches and supply gains. LLY expects 2025 revenues of $58B-$61B, with growth fueled by Mounjaro, Zepbound and other new drug approvals.Eli Lilly and Company (LLY) has reached a significant support level, making it an attractive option for investors from a technical standpoint. Earlier this week, the stock broke through i ...